Comprehensive Therapy

, Volume 27, Issue 3, pp 209–212 | Cite as

Controlling high blood pressure: A simple and effective approach

  • Edward D. Freis
Original Article

Abstract

Fixed-dose combination tablets, such as diuretic plus β-adrenergic blocking drug or ACE inhibitor are more effective than is any monotherapy. Other advantages include simple titration, low toxicity and reduced expense which encourage better compliance required for optimal blood pressure control.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Fisher G. Top 10 reasons for office visits. Scoff-Levin Physicians Drug and Diagnosis Audit Inc, 60 Blacksmith Road, Newtown, PA 18940.Google Scholar
  2. 2.
    Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the U.S. adult population: results from the third National Health and Nutrition Evaluation Survey 1988–1991. Hypertension. 1995;25:305–313.PubMedGoogle Scholar
  3. 3.
    Materson BJ, Reda DJ, Cushman WC, Henderson WG. Results of combination anti-hypertensive therapy after failure of each of the components. Department of Veterans Affairs Cooperative Study Group on Anti-hypertensive Agents. J Hum Hypertens. 1995;9:791–796.PubMedGoogle Scholar
  4. 4.
    Prisant LM, Mathew RN, Papademetriou V, et al. Low-dose drug combination therapy: An alternative first-line approach to hypertension treatment. Am Heart J. 1995;130:359–366.PubMedCrossRefGoogle Scholar
  5. 5.
    SHEP Cooperative Research Group. Prevention of stroke by antihypertensive treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991;265:3255–3264.CrossRefGoogle Scholar
  6. 6.
    Cushman WC, Cohen JD, Jones RP, et al. Comparison of the fixed dose combination of enalapril/diltiazem ER and their monotherapies in stage 1 to 3 essential hypertension. Am J Hypertens. 1998;11:23–30.PubMedCrossRefGoogle Scholar
  7. 7.
    Freis ED, Materson BL. Captopril in mild to moderate hypertension: effect of low dose and of added diuretic. Prog Pharmacol. 1984;5:87–92.Google Scholar
  8. 8.
    AIRE Study Investigators. Effects of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet. 1993;342: 821–828.Google Scholar
  9. 9.
    ACC/AHA Task Force on Practice Guidelines: ACC/AHA guidelines for the management of patients with myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Management of Acute Myocardial Infarction). Circulation. 1996;28:1328–1428.Google Scholar
  10. 10.
    Kuher J. Tarp-Pedersen C, CarlsonJE, et al. A clinical trial of the angiotensin-converting enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. N Engl J Med. 1995;333:1670–1676.CrossRefGoogle Scholar
  11. 11.
    Doodwania PC. Angiotensin converting enzyme Inhibitors in congestive heart failure. Arch Int Med. 1990;150:1798–1805.CrossRefGoogle Scholar
  12. 12.
    Schmeider RE, Martus P, Klinball FL. Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies. JAMA. 1996; 276:275–281.CrossRefGoogle Scholar
  13. 13.
    Bianchi S, Bigazzi R, Balderi G, et al. Microalbuminuria in patients with essential hypertension: effects of an angiotensin enzyme Inhibitor and of a calcium channel blocker. Am J Hypertens. 1991;4:291–296.PubMedGoogle Scholar
  14. 14.
    Bjorck S, Nyberg G, Mulec H, Granerus G, Herlitz H, Aurell M. Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with nephropathy. Br Med J. 1996;293:471–474.CrossRefGoogle Scholar
  15. 15.
    Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low dose aspirin in patients with hypertension: principle results of the Hypertension Optimal Treatment (HOT) Randomized Trial. Lancet. 1998;351:1755–1762.PubMedCrossRefGoogle Scholar
  16. 16.
    Sixth Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC-VI). Arch Intern Med. 1997;157:2413–2446.CrossRefGoogle Scholar
  17. 17.
    Chockalingam A, Bacher M, Campbell N, et al. Adherence to management of high blood pressure: recommendations of the Canadian Coalition for High Blood Pressure Prevention and Control. Can J Public Health. 1998;89(Suppl 1):I5-I11.PubMedGoogle Scholar
  18. 18.
    Haynes RB, McKibbon KA, Kanani R. Systematic review of randomized trials of intervention to assist patients to follow prescriptions for medications. Lancet. 1996;348:383–386.PubMedCrossRefGoogle Scholar
  19. 19.
    Logan AG, Milne BJ, Achber C, Campbell WP, Haynes RB. Work-site treatment of hypertension by specially trained nurses: a controlled trial. Lancet. 1979;2:1175–1178.PubMedCrossRefGoogle Scholar
  20. 20.
    Schultz JF, Sheps SC. Management of patients with hypertension: a hypertension clinic model. Mayo Clinic Proc. 1994;69:997–999.Google Scholar

Copyright information

© Humana Press Inc. 2001

Authors and Affiliations

  • Edward D. Freis
    • 1
    • 2
  1. 1.Hypertension Research ClinicDepartment of Veterans AffairsWashington, D.C.USA
  2. 2.Georgetown University School of MedicineWashington, D.C.USA

Personalised recommendations